PedAM
Pediatric Disease Annotations & Medicines
| Disease | renal cell carcinoma |
| Symptom | C0153690|bone metastases |
| Sentences | 8 |
| PubMedID- 23132391 | Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases. |
| PubMedID- 22965827 | However, it remains unclear whether bisphosphonates improve overall survival (os) for renal cell carcinoma (rcc) patients with bone metastases. |
| PubMedID- 24731497 | Methods: a total of 66 renal cell carcinoma patients with bone metastases treated at our hospital between october 1990 and october 2010 were divided into 3 groups: solitary bone metastasis referred for radical surgery (n = 19); palliative surgery for solitary/multiple bone metastasis (n = 31); extraosseous metastasis without orthopedic surgery (n = 16). |
| PubMedID- 20809091 | Background: the use of zoledronic acid (zol) has recently been shown to significantly reduce the risk of new skeletal-related events (sres) in renal cell carcinoma (rcc) patients with bone metastases. |
| PubMedID- 20937648 | Background: the aim of our study was to determine whether the presence of bone metastases affects outcomes in patients with metastatic clear-cell renal cell carcinoma (m-ccrcc) receiving sunitinib. |
| PubMedID- 24063967 | Background: surgery remains the main treatment of bone metastases due to renal cell carcinoma (rcc). |
| PubMedID- 25651794 | bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis. |
| PubMedID- 23900392 | (c) atm serine-1981 phosphorylation was induced 3.2-fold in blood collected before and after sbrt for a metastatic renal cell carcinoma with bone metastases. |
Page: 1